|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash (used in) operating activities: | |||||
| Stock based compensation | |||||
| Common stock issued for service | |||||
| Write-off of PPE | |||||
| Depreciation of fixed assets | |||||
| Amortization of debt discounts | |||||
| Allowance for inventory obsolescence | |||||
| Allowance for advances and Related Party long-term receivable | |||||
| Loss on settlement of debt | |||||
| Lease expense | |||||
| Credit loss expense | |||||
| (Gain) loss on revaluation of fair value of derivative and warrant liabilities | |||||
| Change in fair value of derivative liabilities | |||||
| Change in fair value of convertible notes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivables | |||||
| Inventories | |||||
| Advances to related parties | |||||
| Other current assets | |||||
| Right of use liability | |||||
| Other assets | |||||
| Accounts payable and accruals | |||||
| Accrued compensation | |||||
| Customer refunds | |||||
| Deferred income | |||||
| Other current liabilities | |||||
| Net Cash (Used in) Operating Activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of fixed assets | |||||
| Net Cash (Used in) Investing Activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from common stock offering – prefunded warrants | |||||
| Proceeds from common stock offering | |||||
| Proceeds from sale of prefunded warrants | |||||
| Proceeds from working capital line of credit | |||||
| Proceeds from short-term loan | |||||
| Proceeds from convertible debt | |||||
| Repayments of working capital line of credit | |||||
| Repayments of short-term loan | |||||
| Principal payments of convertible debt | |||||
| Repayments of related party notes payable | |||||
| Purchase of treasury stock | |||||
| Net Cash Provided by Financing Activities | |||||
| Effect of Exchange Rate Changes on Cash | |||||
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD | |||||
| CASH AND CASH EQUIVALENTS – END OF PERIOD | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid for interest | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES AND FINANCING ACTIVITIES | |||||
| Common stock issued to settle related party notes payable and accrued interest | |||||
| Common stock issued for partial settlement of note payable | |||||
| Common stock issued for loan commitment fees | |||||
| Derivative liability recognized on issuance of convertible note | |||||
| Warrant liability recognized on issuance of convertible note | |||||
| Common stock issued to settle subordinated related party note | |||||
| Common stock issued for directors stock compensation | |||||
| Director’s compensation included in advances to related parties | |||||
Loading...